Tag: Remdesivir
Cipla sees a steady growth in various markets
It has been 7 years since Samina Hamied, the niece of YK Hamied, joined the board of Cipla. And during this period, the journey...
Jubilant seeks DGCI authorization for oral Remdesivir next steps
On 19 April 2021, Noida-Delhi NCR-based Jubilant Pharmova announced the development of a novel oral formulation of Remdesivir by its subsidiary Jubilant Pharma with...
Pfizer & Gilead partners to manufacture Remdesivir
Pfizer announced a multi-year agreement with Gilead Sciences, to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of the multiple external manufacturing organizations...
Sovereign Pharma dispatches first batch of Remdesivir injections to Cipla
The Daman-based Sovereign Pharma is manufacturing the antiviral drug for Indian pharmaceutical giant Cipla, as it continues to be one of the few effective...
Hetero Healthcare to supply 20,000 vials of Covifor generic Remdesivir
Hetero Healthcare is set to deliver the first set of 20,000 vials of its antiviral drug Covfir (generic version of Remdesivir), in two equal...
Cipla launches remdesivir under brand name CIPREMI
Cipla announced the launch of remdesivir under its brand name CIPREMI. The USFDA issued an Emergency Use Authorization (EUA) to Gilead Sciences for emergency...
Lilly starts phase 3 clinical trial with Baricitinib for hospitalized Covid-19...
Eli Lilly and Company announced that the first patient had been enrolled in Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and...
Roche initiates phase III clinical trial of Actemra, RoActemra and remdesivir
Roche announced the initiation of a global phase III, randomized, double-blind, multicenter study (REMDACTA) to evaluate the safety and efficacy of Actemra, RoActemra, and...